<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Arno Therapeutics — News on 6ix</title>
<link>https://6ix.com/company/arno-therapeutics</link>
<description>Latest news and press releases for Arno Therapeutics on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 22 Dec 2017 14:11:12 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/arno-therapeutics" rel="self" type="application/rss+xml" />
<item>
<title>Arno Therapeutics Announces Plans to Dissolve</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-announces-plans-to-dissolve</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-announces-plans-to-dissolve</guid>
<pubDate>Fri, 22 Dec 2017 14:11:12 GMT</pubDate>
<description>Arno Therapeutics Announces Plans to Dissolve.</description>
</item>
<item>
<title>Arno Therapeutics Announces Plan to Deregister its Common Stock</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-announces-plan-to-deregister-its-common-stock</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-announces-plan-to-deregister-its-common-stock</guid>
<pubDate>Tue, 28 Mar 2017 11:37:11 GMT</pubDate>
<description>Arno Therapeutics Announces Plan to Deregister its Common Stock.</description>
</item>
<item>
<title>Arno Therapeutics Announces Update to Onapristone Prostate Cancer Development Program</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-announces-update-to-onapristone-prostate-cancer-development-program</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-announces-update-to-onapristone-prostate-cancer-development-program</guid>
<pubDate>Wed, 04 Jan 2017 21:22:41 GMT</pubDate>
<description>Arno Therapeutics Announces Update to Onapristone Prostate Cancer Development Program.</description>
</item>
<item>
<title>Arno Therapeutics Announces Cancellation of Special Meeting of Stockholders</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-announces-cancellation-of-special-meeting-of-stockholders</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-announces-cancellation-of-special-meeting-of-stockholders</guid>
<pubDate>Wed, 21 Dec 2016 21:11:41 GMT</pubDate>
<description>Arno Therapeutics Announces Cancellation of Special Meeting of Stockholders.</description>
</item>
<item>
<title>Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-third-quarter-2016-financial-and-business-update</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-third-quarter-2016-financial-and-business-update</guid>
<pubDate>Mon, 14 Nov 2016 22:04:45 GMT</pubDate>
<description>Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update.</description>
</item>
<item>
<title>Arno Therapeutics Reports Second Quarter 2016 Financial and Business Update</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-second-quarter-2016-financial-and-business-update</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-second-quarter-2016-financial-and-business-update</guid>
<pubDate>Mon, 22 Aug 2016 21:45:41 GMT</pubDate>
<description>Arno Therapeutics Reports Second Quarter 2016 Financial and Business Update.</description>
</item>
<item>
<title>Arno Completes $2.8 Million Private Placement</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-completes-dollar28-million-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-completes-dollar28-million-private-placement</guid>
<pubDate>Mon, 22 Aug 2016 15:06:43 GMT</pubDate>
<description>Arno Completes $2.8 Million Private Placement.</description>
</item>
<item>
<title>Arno Therapeutics Reports First Quarter 2016 Financial and Business Update</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-first-quarter-2016-financial-and-business-update</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-first-quarter-2016-financial-and-business-update</guid>
<pubDate>Mon, 16 May 2016 20:49:38 GMT</pubDate>
<description>Arno Therapeutics Reports First Quarter 2016 Financial and Business Update.</description>
</item>
<item>
<title>UCLA's Dr. Stuart Holden Interviewed by The Life Sciences Report</title>
<link>https://6ix.com/company/arno-therapeutics/news/uclas-dr-stuart-holden-interviewed-by-the-life-sciences-report</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/uclas-dr-stuart-holden-interviewed-by-the-life-sciences-report</guid>
<pubDate>Thu, 21 Apr 2016 13:49:07 GMT</pubDate>
<description>UCLA's Dr. Stuart Holden Interviewed by The Life Sciences Report.</description>
</item>
<item>
<title>Arno Therapeutics to Focus Clinical Developmental Activities on Advanced Prostate Cancer in First-of-its-Kind Phase II Study of Onapristone in Combination with ZYTIGA®</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-to-focus-clinical-developmental-activities-on-advanced-prostate-cancer-in-first-of-its-kind-phase-ii-study-of-onapristone-in-combination-with-zytigar</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-to-focus-clinical-developmental-activities-on-advanced-prostate-cancer-in-first-of-its-kind-phase-ii-study-of-onapristone-in-combination-with-zytigar</guid>
<pubDate>Tue, 19 Apr 2016 12:18:10 GMT</pubDate>
<description>Arno Therapeutics to Focus Clinical Developmental Activities on Advanced Prostate Cancer in First-of-its-Kind Phase II Study of Onapristone in Combination with ZYTIGA®.</description>
</item>
<item>
<title>Arno Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-fourth-quarter-and-full-year-2015-financial-results-and-business-update</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-fourth-quarter-and-full-year-2015-financial-results-and-business-update</guid>
<pubDate>Wed, 30 Mar 2016 20:34:01 GMT</pubDate>
<description>Arno Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update.</description>
</item>
<item>
<title>Arno Therapeutics Advances Phase I/II Trial Evaluating Onapristone in Prostate Cancer to Phase II</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-advances-phase-iii-trial-evaluating-onapristone-in-prostate-cancer-to-phase-ii</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-advances-phase-iii-trial-evaluating-onapristone-in-prostate-cancer-to-phase-ii</guid>
<pubDate>Mon, 21 Mar 2016 11:46:58 GMT</pubDate>
<description>Arno Therapeutics Advances Phase I/II Trial Evaluating Onapristone in Prostate Cancer to Phase II.</description>
</item>
<item>
<title>Arno Therapeutics Completes $7.4 Million Common Stock Financing</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-completes-dollar74-million-common-stock-financing</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-completes-dollar74-million-common-stock-financing</guid>
<pubDate>Wed, 13 Jan 2016 12:43:34 GMT</pubDate>
<description>Arno Therapeutics Completes $7.4 Million Common Stock Financing.</description>
</item>
<item>
<title>Arno Therapeutics Reports Third Quarter 2015 Financial Results and Business Update</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-third-quarter-2015-financial-results-and-business-update</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-reports-third-quarter-2015-financial-results-and-business-update</guid>
<pubDate>Mon, 16 Nov 2015 21:11:29 GMT</pubDate>
<description>Arno Therapeutics Reports Third Quarter 2015 Financial Results and Business Update.</description>
</item>
<item>
<title>Arno Therapeutics Data Demonstrate AR-12 as Novel Antifungal Drug Against Common Finger and Toenail Fungus, Onychomycosis</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-data-demonstrate-ar-12-as-novel-antifungal-drug-against-common-finger-and-toenail-fungus-onychomycosis</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-data-demonstrate-ar-12-as-novel-antifungal-drug-against-common-finger-and-toenail-fungus-onychomycosis</guid>
<pubDate>Thu, 29 Oct 2015 11:09:37 GMT</pubDate>
<description>Arno Therapeutics Data Demonstrate AR-12 as Novel Antifungal Drug Against Common Finger and Toenail Fungus, Onychomycosis.</description>
</item>
<item>
<title>Arno Therapeutics Demonstrates AR-12 Has Potent Antiviral Activity Against Drug-Resistant HIV Strains</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-demonstrates-ar-12-has-potent-antiviral-activity-against-drug-resistant-hiv-strains</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-demonstrates-ar-12-has-potent-antiviral-activity-against-drug-resistant-hiv-strains</guid>
<pubDate>Wed, 21 Oct 2015 14:10:31 GMT</pubDate>
<description>Arno Therapeutics Demonstrates AR-12 Has Potent Antiviral Activity Against Drug-Resistant HIV Strains.</description>
</item>
<item>
<title>Arno Therapeutics to Present Late-Breaking Abstract on AR-12 as Novel Therapeutic Candidate Against HIV Multidrug Resistant Strains at 15th European AIDS Conference</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-to-present-late-breaking-abstract-on-ar-12-as-novel-therapeutic-candidate-against-hiv-multidrug-resistant-strains-at-15th-european-aids-conference</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-to-present-late-breaking-abstract-on-ar-12-as-novel-therapeutic-candidate-against-hiv-multidrug-resistant-strains-at-15th-european-aids-conference</guid>
<pubDate>Fri, 25 Sep 2015 10:08:06 GMT</pubDate>
<description>Arno Therapeutics to Present Late-Breaking Abstract on AR-12 as Novel Therapeutic Candidate Against HIV Multidrug Resistant Strains at 15th European AIDS Conference.</description>
</item>
<item>
<title>Arno Therapeutics' AR-13 Data Show Promise as Potential New Therapeutic Option for Cystic Fibrosis Patients With Serious Bacterial Infections</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-ar-13-data-show-promise-as-potential-new-therapeutic-option-for-cystic-fibrosis-patients-with-serious-bacterial-infections</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-ar-13-data-show-promise-as-potential-new-therapeutic-option-for-cystic-fibrosis-patients-with-serious-bacterial-infections</guid>
<pubDate>Thu, 24 Sep 2015 11:08:11 GMT</pubDate>
<description>Arno Therapeutics' AR-13 Data Show Promise as Potential New Therapeutic Option for Cystic Fibrosis Patients With Serious Bacterial Infections.</description>
</item>
<item>
<title>Arno Therapeutics Data Demonstrates Novel Antimicrobial Activity of AR-12, Identified it as Lead Compound of New Class of Drugs</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-data-demonstrates-novel-antimicrobial-activity-of-ar-12-identified-it-as-lead-compound-of-new-class-of-drugs</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-data-demonstrates-novel-antimicrobial-activity-of-ar-12-identified-it-as-lead-compound-of-new-class-of-drugs</guid>
<pubDate>Sat, 19 Sep 2015 20:07:01 GMT</pubDate>
<description>Arno Therapeutics Data Demonstrates Novel Antimicrobial Activity of AR-12, Identified it as Lead Compound of New Class of Drugs.</description>
</item>
<item>
<title>Arno Therapeutics to Present Data on Trans-Fungal Delivery of AR-12 at 2015 American Association of Pharmaceutical Scientists (AAPS) Annual Exposition</title>
<link>https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-to-present-data-on-trans-fungal-delivery-of-ar-12-at-2015-american-association-of-pharmaceutical-scientists-aaps-annual-exposition</link>
<guid isPermaLink="true">https://6ix.com/company/arno-therapeutics/news/arno-therapeutics-to-present-data-on-trans-fungal-delivery-of-ar-12-at-2015-american-association-of-pharmaceutical-scientists-aaps-annual-exposition</guid>
<pubDate>Sat, 19 Sep 2015 12:07:31 GMT</pubDate>
<description>Arno Therapeutics to Present Data on Trans-Fungal Delivery of AR-12 at 2015 American Association of Pharmaceutical Scientists (AAPS) Annual Exposition.</description>
</item>
</channel>
</rss>